€4.7B Irish R&D scheme threatens move

An Irish businessman's grand plan to build the world's largest R&D hub--the ambitiously titled Global Pharmaceutical Centre of Excellence--has attracted the avid interest of the country's many newspapers. And now backers are once again in the headlines with a threat to take their project and go to the North if local economic development officials don't deliver the support they'll need. At stake, backers claim, is a €4.7 billion project that could deliver some 4,500 jobs at a time many of the major pharma companies have been scaling back in the country. Story

Suggested Articles

Novo is working on a once-weekly basal insulin that could cut down on injections for people with Type 2 diabetes, and the phase 2 data look promising.

The money will support work on a biologic drug cocktail that Lumen thinks can be a scalable, inexpensive fix for gastrointestinal symptoms.

The readouts link the oral oxidative phosphorylation blocker imeglimin to near- and long-term improvements when given as a monotherapy and in combos.